Dare Bioscience, Inc. Total Liabilities and Equity
Dare Bioscience, Inc. (DARE) had Total Liabilities and Equity of $22.37 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-13
- 2026-06-30: Liabilities and Equity $22.37M.
- 2026-03-31: Liabilities and Equity $27.83M.
- 2025-12-31: Liabilities and Equity $32.47M.
- 2025-09-30: Liabilities and Equity $30.75M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $22.37M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $27.83M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $32.47M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $30.75M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $12.98M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $18.62M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $22.10M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $18.06M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $23.61M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $13.01M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $21.28M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $25.05M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $23.21M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $30.37M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $43.83M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $50.38M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $51.39M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $49.19M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $55.81M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $48.81M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $14.82M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $10.52M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $7.55M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $7.66M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $8.57M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $10.21M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $7.44M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $3.88M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $7.26M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $5.02M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $7.83M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $10.80M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $13.48M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $16.63M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $14.26M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $23.27M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $42.20K 8-K/A · filed 2017-10-02 | $8.15M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $15.95M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $44.61K 10-K · filed 2018-03-28 | $37.69M 10-K · filed 2017-03-31 |
| 2016-09-30 | $40.13M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $49.89M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $63.02M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $469.41K 8-K/A · filed 2017-10-02 | $78.22M 10-K · filed 2016-03-10 |
| 2015-09-30 | $80.12M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $88.10M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $59.38M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $53.39M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $60.09M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $65.74M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $11.85M 10-Q · filed 2014-05-27 | |
| 2013-12-31 | $6.83M 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |